Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed ‌18,410 ​times in the U.S. in ‌the first full week after its ...

A framework is now in place for investigating the "potentials and risks" of new nuclear technologies - including small modular reactors - and the lifting of a moratorium on nuclear power, Denmark's ...

Florida State University is looking to participate in what could be a groundbreaking drug discovery study through a Denmark-based research consortium.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Novo Nordisk A/S (NVO) kicked off 2026 with a major milestone: the U.S. launch of the Wegovy weight-loss pill. This marks the first oral GLP-1 therapy, which was approved by the Food and Drug ...

Novo Nordisk has found a buyer for cell therapy technologies dropped in its retreat from the modality. Aspect Biosystems has ...

The iShares MSCI Denmark ETF is rated a buy, supported by Denmark’s strong fundamentals and macroeconomic tailwinds. Learn ...

Aspect will acquire rights from Novo Nordisk to stem cell-derived islet cell and hypoimmune cell engineering technologies.

Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have struck a ...

O n january 18th, after Donald Trump repeated his threat to take over Greenland and announced tariffs on Denmark and seven ...

Novo Nordisk agreed to invest in Aspect Biosystems and provide research funding as the companies extend an existing ...